N/A N=35 Study of Early Endocapsule (EC) in Clinical Decision Unit Versus Standard of Care Work-up for GI Bleeding
Gastro Intestinal Bleeding · Hematemesis · Melena
Primary: Rate of Detection of Bleeding — 11; 11 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=27 Nivolumab With or Without Ipilimumab in Treating Patients With Resectable Liver Cancer
Hepatocellular Carcinoma · Resectable Hepatocellular Carcinoma
Primary: Safety and Tolerability of Presurgical Nivolumab With or Without Ipilimumab, Defined as the Number of Participants With of Adverse Events. — 13; 14; 0 Participants
Phase 2 N=10 Low-Dose Ketamine in Children With ADNP Syndrome
ADNP Syndrome
Primary: Number of Participants With an Adverse Event — 9 Participants
Phase 1 N=6 Study to Evaluate Safety and Tolerability of a Single Dose of PF-06741086 in Chinese Adult Participants With Severe Hemophilia
Severe Hemophilia
Primary: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) — 1; 0; 0 Participants
N/A N=41 New Reusable Mask Design With Superior Filtration and Fit
Covid19 · Tuberculosis · Respiratory Viral Infection
Primary: Comparison of Fit Tests — 39; 39; 40 Participants
N/A N=1,226 This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients.
Arthritis Rheumatoid
Primary: Disease Activity Score 28 (DAS28) at Month 12 — 4.56; 4.9 Units on a scale — p=<0.05
N/A N=96 The Effect of Loop Diuretics on Severity and Outcome of Acute Kidney Injury
Acute Kidney Failure
Primary: Progression to Stage 3 AKI — 23 Participants
N/A N=160 Lay Health Worker Engage, Educate, and Encourage Patients to Share
End of Life · Cancer
Primary: Patient Quality of Life Using the Functional Assessment of Cancer Therapy - General Survey — 74.1; 73.5; 70.3; 80.7 score on a scale — p=<0.001
N/A N=48 Pathways for Parents After Incarceration Feasibility Study
Parenting · Development, Child · Behavior
Primary: Proportion of Eligible Fathers and Caregivers Who Consent — 0.49; 1.0 proportion of participants
N/A N=12 Insulin Pump Therapy in Adolescents With Newly Diagnosed Type 1 Diabetes (T1D)
Diabetes Mellitus, Insulin-Dependent
Primary: Insulin Sensitivity — 8.6; 6.2; 5.8; 4.8 mg/kg/min
Phase 3 N=370 Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery Including a Corneal Endothelial Cell Sub-study
Ocular Inflammation and Pain After Cataract Surgery
Primary: Participants With ACC Count = 0 in the Operated Study Eye at All Visits From Postoperative Day 8 Through Postoperative Day 15 Without Rescue Medication — 49; 16…
Phase 2 N=224 Zelquistinel in the Treatment of Adults With Major Depressive Disorder
Major Depressive Disorder
Primary: Part A: Change in MADRS Score at 1 Day the Initial Dose of AGN-241751 Reported as Change From Baseline in Treated Group Compared With Change From Baseline in Placebo…
Phase 1 N=102 Safety, Tolerability, and Immunogenicity of a Polyvalent Pneumococcal Conjugate Vaccine (V116) in Japanese Adults (V116-002)
Pneumococcal Infection
Primary: Percentage of Participants With a Solicited Injection-site Adverse Event (AE) — 9.8; 9.8; 54.9; 66.7 Percentage of Participants
Phase 2 N=29 M6620 (VX-970) in Selected Solid Tumors
Solid Tumor · Leiomyosarcoma · Osteosarcoma
Primary: Changes in Phospho-Chk1 Levels in Biopsy Specimens — 156; 196; 89; 84 percent change
Phase 2 N=30 A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer
Breast Cancer · Head and Neck Squamous Cell Carcinoma · Colorectal Cancer
Primary: Measure Mean Fluorescence Intensity of Histologically Confirmed Tumor vs Normal Tissue in Patients Undergoing Routine Surgery [Tumor to Background Ratio (TBR)] — 1.098…